biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	1951BFBC-A7CD-4827-A9EE-E06528D41793
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EF-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EF-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EF-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433603
biospecimen__bio__day_of_creation	27
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EF.002B24F9-22DB-4504-A048-BF9790A4837E.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	C
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EF
biospecimen__shared__patient_id	A1EF
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	37ACC77D-6FD9-4DB9-BCB8-8ACBF3ECB443
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.5
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	16211
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.4
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	12.0
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	8.5
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	57
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EF-F42200
clinical__clin_shared__bcr_followup_uuid	47AD5204-D003-453C-87E7-016B94CE33E3
clinical__clin_shared__cancer_first_degree_relative	9
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__platelet_result_count	337
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2007
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	786e8c1a-7119-48b4-8670-7a04372a2d1c
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EF-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	aadd2ebd-39f1-401f-a7df-d6a456ac2bf9
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	b731d968-5c9c-4400-ab0e-a90fa41c1d9e
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	1c1e8987-676f-417b-b3b4-e0321367df55
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	e2a374fb-1102-5742-a7cb-db94ab64c851
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1950
gdc__demographic__year_of_death	2008
gdc__diagnoses__age_at_diagnosis	21165
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-21165.0
gdc__diagnoses__days_to_death	394.0
gdc__diagnoses__diagnosis_id	948e6eab-95dc-535c-8717-5ad2890147c0
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	30.116002379535992
gdc__exposures__exposure_id	07118d4c-8027-5e7c-94e2-ab7c72b670da
gdc__exposures__height	164.0
gdc__exposures__weight	81.0
gdc__file_id	6318731e-18af-453b-b5bf-d0f6b62939d1
gdc__file_name	97640a9e-59b7-4f5d-a654-c6893e4fa416.mirbase21.mirnas.quantification.txt
gdc__file_size	50415
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	31526229c53b72a17a0a33b98cbf0af7
gdc__portions__is_ffpe	false
gdc__portions__portion_id	3bdd352d-b820-4938-b604-b77bf0a3c0ac
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1382
gdc__samples__initial_weight	190.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	002B24F9-22DB-4504-A048-BF9790A4837E
gdc__samples__sample_id	f11e2b07-2848-4601-b19f-eed188aa4c3b
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	5c8901cb-3d53-43d4-8bb4-26e1f8797a90
gdc__submitter_id	mirna_swap_dr11_361_MirnaExpression293b64a8-acbc-40d1-bc7b-e36ecd531ad4_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	24e5dc72-a173-555d-a62e-6468ca46383a
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:29.942+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/786e8c1a-7119-48b4-8670-7a04372a2d1c-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/786e8c1a-7119-48b4-8670-7a04372a2d1c-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129786
manually_curated__local_md5	2d5a0bc796d78c835086e8e23a03aafc
manually_curated__opengdc_download_date	2018-10-16T17:12:20.000887+02:00
manually_curated__opengdc_file_md5	ff4d049bfbaab406fb52bff58449f428
manually_curated__opengdc_file_size	50414
manually_curated__opengdc_id	786e8c1a-7119-48b4-8670-7a04372a2d1c-meq
manually_curated__origin_file_size	129786
manually_curated__origin_last_modified_date	Tue Oct 16 17:37:00 CEST 2018
manually_curated__origin_md5	2d5a0bc796d78c835086e8e23a03aafc
manually_curated__tissue_status	tumoral
